Saudi Arabia’s Almoosa Health Group Visits Jiahui International Hospital

ShanghaiApril 30, 2026 /PRNewswire/ — In April 2026, Jiahui Health was honored to welcome a delegation from Almoosa Health Group of Saudi Arabia. The delegation was led by the Group’s CEO, Dr. Malek Almoosa, and included senior leaders from business units such as supply chain, portfolio management, procurement, and contract management.

This visit provided a valuable platform for in-depth exchange and mutual learning between the two parties. The discussions covered a wide range of topics, including hospital design and infrastructure construction, operational excellence practices, and innovative diagnosis and treatment service models. Both sides also explored potential synergies between the healthcare industries of Saudi Arabia and China, looking ahead to opportunities for future collaboration.

A core theme throughout the dialogue was China’s rapid rise as a global hub for healthcare and life sciences innovation. This includes breakthroughs in advanced therapies such as CAR-T cell therapy—the world’s first CAR-T therapy for treating solid tumors is expected to launch in China in the first half of 2026. As part of this progress, Jiahui International Hospital will provide patients with access to these cutting-edge cancer treatment solutions.

At the same time, China’s healthcare ecosystem is rapidly advancing in the application of artificial intelligence, including in areas such as radiology, where AI-assisted diagnostics are enhancing accuracy, efficiency, and clinical decision-making. These developments, along with ongoing innovations in pharmaceuticals, medical devices, and patient-centered service models, collectively underscore China’s growing leadership in global healthcare innovation.

As one of the landmark institutions in Shanghai’s international hospital sector, Jiahui International Hospital is proud to contribute to this momentum—not only as a provider of high-quality medical services, but also as a platform for international collaboration, knowledge sharing, and innovative partnerships. We look forward to continuing the dialogue and exploring meaningful partnerships to advance cross-border healthcare services.